Saturday, November 28, 2020

Fw: (LML) Replacing opinions about leprosy treatment with research

 

Leprosy Mailing List – November 28,  2020

Ref.:  (LML) Replacing opinions about leprosy treatment with research

From:  P. Ajit, Maharashtra, India

_________________________________________________________________________ 

 

Dear Pieter,


Totally agree with Dr Narsimha Rao Sir's views regarding daily rifampicin (LML, November 23, 2020).


The same thing was always mentioned in leprosy chapter in Harrison textbook by 

Dr Robert Gelber. I think since he is on the group he can share his views regarding the same. 

 

Regarding safety, in large number of tuberculosis patients, rifampicin  is used on a daily basis and we do have robust safety data.

 

Thanks,

 

Dr Ajit.

___________________________________________________________________________

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << edit...@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/0ced5064-6847-4da5-abb5-9503cdbaf70bn%40googlegroups.com.

No comments: